The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Leukocyte Antigen Testing Market Research Report 2025
Synopsis
A blood test equipment that identifies antigens on the surface of cells and tissues.
The global Human Leukocyte Antigen Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Leukocyte Antigen Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Leukocyte Antigen Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Human Leukocyte Antigen Testing include Thermo Fisher Scientific, F. Hoffman-La Roche, Bio-Rad Laboratories, QIAGEN N.V., Illumina, Immucor, CareDx, Becton Dickinson and Hologic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Leukocyte Antigen Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Leukocyte Antigen Testing.
Report Scope
The Human Leukocyte Antigen Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Leukocyte Antigen Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Leukocyte Antigen Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
F. Hoffman-La Roche
Bio-Rad Laboratories
QIAGEN N.V.
Illumina
Immucor
CareDx
Becton Dickinson
Hologic
GenDx
Biofortuna
Segment by Type
Molecular Assay Technologies
Non-molecular Assay Technologies
Segment by Application
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Leukocyte Antigen Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Leukocyte Antigen Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A blood test equipment that identifies antigens on the surface of cells and tissues.
The global Human Leukocyte Antigen Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Leukocyte Antigen Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Leukocyte Antigen Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Human Leukocyte Antigen Testing include Thermo Fisher Scientific, F. Hoffman-La Roche, Bio-Rad Laboratories, QIAGEN N.V., Illumina, Immucor, CareDx, Becton Dickinson and Hologic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Leukocyte Antigen Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Leukocyte Antigen Testing.
Report Scope
The Human Leukocyte Antigen Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Leukocyte Antigen Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Leukocyte Antigen Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
F. Hoffman-La Roche
Bio-Rad Laboratories
QIAGEN N.V.
Illumina
Immucor
CareDx
Becton Dickinson
Hologic
GenDx
Biofortuna
Segment by Type
Molecular Assay Technologies
Non-molecular Assay Technologies
Segment by Application
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Leukocyte Antigen Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Leukocyte Antigen Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Leukocyte Antigen Testing Market Overview
1.1 Product Overview and Scope of Human Leukocyte Antigen Testing
1.2 Human Leukocyte Antigen Testing Segment by Type
1.2.1 Global Human Leukocyte Antigen Testing Market Value Comparison by Type (2024-2030)
1.2.2 Molecular Assay Technologies
1.2.3 Non-molecular Assay Technologies
1.3 Human Leukocyte Antigen Testing Segment by Application
1.3.1 Global Human Leukocyte Antigen Testing Market Value by Application: (2024-2030)
1.3.2 Independent Reference Laboratories
1.3.3 Hospitals & Transplant Centers
1.3.4 Research Laboratories & Academic Institutes
1.4 Global Human Leukocyte Antigen Testing Market Size Estimates and Forecasts
1.4.1 Global Human Leukocyte Antigen Testing Revenue 2019-2030
1.4.2 Global Human Leukocyte Antigen Testing Sales 2019-2030
1.4.3 Global Human Leukocyte Antigen Testing Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Leukocyte Antigen Testing Market Competition by Manufacturers
2.1 Global Human Leukocyte Antigen Testing Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Leukocyte Antigen Testing Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Leukocyte Antigen Testing Average Price by Manufacturers (2019-2024)
2.4 Global Human Leukocyte Antigen Testing Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Leukocyte Antigen Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Leukocyte Antigen Testing, Product Type & Application
2.7 Human Leukocyte Antigen Testing Market Competitive Situation and Trends
2.7.1 Human Leukocyte Antigen Testing Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Leukocyte Antigen Testing Players Market Share by Revenue
2.7.3 Global Human Leukocyte Antigen Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Leukocyte Antigen Testing Retrospective Market Scenario by Region
3.1 Global Human Leukocyte Antigen Testing Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Leukocyte Antigen Testing Global Human Leukocyte Antigen Testing Sales by Region: 2019-2030
3.2.1 Global Human Leukocyte Antigen Testing Sales by Region: 2019-2024
3.2.2 Global Human Leukocyte Antigen Testing Sales by Region: 2025-2030
3.3 Global Human Leukocyte Antigen Testing Global Human Leukocyte Antigen Testing Revenue by Region: 2019-2030
3.3.1 Global Human Leukocyte Antigen Testing Revenue by Region: 2019-2024
3.3.2 Global Human Leukocyte Antigen Testing Revenue by Region: 2025-2030
3.4 North America Human Leukocyte Antigen Testing Market Facts & Figures by Country
3.4.1 North America Human Leukocyte Antigen Testing Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Leukocyte Antigen Testing Sales by Country (2019-2030)
3.4.3 North America Human Leukocyte Antigen Testing Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Leukocyte Antigen Testing Market Facts & Figures by Country
3.5.1 Europe Human Leukocyte Antigen Testing Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Leukocyte Antigen Testing Sales by Country (2019-2030)
3.5.3 Europe Human Leukocyte Antigen Testing Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Leukocyte Antigen Testing Market Facts & Figures by Country
3.6.1 Asia Pacific Human Leukocyte Antigen Testing Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Leukocyte Antigen Testing Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Leukocyte Antigen Testing Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Leukocyte Antigen Testing Market Facts & Figures by Country
3.7.1 Latin America Human Leukocyte Antigen Testing Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Leukocyte Antigen Testing Sales by Country (2019-2030)
3.7.3 Latin America Human Leukocyte Antigen Testing Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Leukocyte Antigen Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Leukocyte Antigen Testing Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Leukocyte Antigen Testing Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Leukocyte Antigen Testing Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Leukocyte Antigen Testing Sales by Type (2019-2030)
4.1.1 Global Human Leukocyte Antigen Testing Sales by Type (2019-2024)
4.1.2 Global Human Leukocyte Antigen Testing Sales by Type (2025-2030)
4.1.3 Global Human Leukocyte Antigen Testing Sales Market Share by Type (2019-2030)
4.2 Global Human Leukocyte Antigen Testing Revenue by Type (2019-2030)
4.2.1 Global Human Leukocyte Antigen Testing Revenue by Type (2019-2024)
4.2.2 Global Human Leukocyte Antigen Testing Revenue by Type (2025-2030)
4.2.3 Global Human Leukocyte Antigen Testing Revenue Market Share by Type (2019-2030)
4.3 Global Human Leukocyte Antigen Testing Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Leukocyte Antigen Testing Sales by Application (2019-2030)
5.1.1 Global Human Leukocyte Antigen Testing Sales by Application (2019-2024)
5.1.2 Global Human Leukocyte Antigen Testing Sales by Application (2025-2030)
5.1.3 Global Human Leukocyte Antigen Testing Sales Market Share by Application (2019-2030)
5.2 Global Human Leukocyte Antigen Testing Revenue by Application (2019-2030)
5.2.1 Global Human Leukocyte Antigen Testing Revenue by Application (2019-2024)
5.2.2 Global Human Leukocyte Antigen Testing Revenue by Application (2025-2030)
5.2.3 Global Human Leukocyte Antigen Testing Revenue Market Share by Application (2019-2030)
5.3 Global Human Leukocyte Antigen Testing Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Human Leukocyte Antigen Testing Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Scientific Human Leukocyte Antigen Testing Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 F. Hoffman-La Roche
6.2.1 F. Hoffman-La Roche Corporation Information
6.2.2 F. Hoffman-La Roche Description and Business Overview
6.2.3 F. Hoffman-La Roche Human Leukocyte Antigen Testing Sales, Revenue and Gross Margin (2019-2024)
6.2.4 F. Hoffman-La Roche Human Leukocyte Antigen Testing Product Portfolio
6.2.5 F. Hoffman-La Roche Recent Developments/Updates
6.3 Bio-Rad Laboratories
6.3.1 Bio-Rad Laboratories Corporation Information
6.3.2 Bio-Rad Laboratories Description and Business Overview
6.3.3 Bio-Rad Laboratories Human Leukocyte Antigen Testing Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bio-Rad Laboratories Human Leukocyte Antigen Testing Product Portfolio
6.3.5 Bio-Rad Laboratories Recent Developments/Updates
6.4 QIAGEN N.V.
6.4.1 QIAGEN N.V. Corporation Information
6.4.2 QIAGEN N.V. Description and Business Overview
6.4.3 QIAGEN N.V. Human Leukocyte Antigen Testing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 QIAGEN N.V. Human Leukocyte Antigen Testing Product Portfolio
6.4.5 QIAGEN N.V. Recent Developments/Updates
6.5 Illumina
6.5.1 Illumina Corporation Information
6.5.2 Illumina Description and Business Overview
6.5.3 Illumina Human Leukocyte Antigen Testing Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Illumina Human Leukocyte Antigen Testing Product Portfolio
6.5.5 Illumina Recent Developments/Updates
6.6 Immucor
6.6.1 Immucor Corporation Information
6.6.2 Immucor Description and Business Overview
6.6.3 Immucor Human Leukocyte Antigen Testing Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Immucor Human Leukocyte Antigen Testing Product Portfolio
6.6.5 Immucor Recent Developments/Updates
6.7 CareDx
6.6.1 CareDx Corporation Information
6.6.2 CareDx Description and Business Overview
6.6.3 CareDx Human Leukocyte Antigen Testing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CareDx Human Leukocyte Antigen Testing Product Portfolio
6.7.5 CareDx Recent Developments/Updates
6.8 Becton Dickinson
6.8.1 Becton Dickinson Corporation Information
6.8.2 Becton Dickinson Description and Business Overview
6.8.3 Becton Dickinson Human Leukocyte Antigen Testing Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Becton Dickinson Human Leukocyte Antigen Testing Product Portfolio
6.8.5 Becton Dickinson Recent Developments/Updates
6.9 Hologic
6.9.1 Hologic Corporation Information
6.9.2 Hologic Description and Business Overview
6.9.3 Hologic Human Leukocyte Antigen Testing Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hologic Human Leukocyte Antigen Testing Product Portfolio
6.9.5 Hologic Recent Developments/Updates
6.10 GenDx
6.10.1 GenDx Corporation Information
6.10.2 GenDx Description and Business Overview
6.10.3 GenDx Human Leukocyte Antigen Testing Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GenDx Human Leukocyte Antigen Testing Product Portfolio
6.10.5 GenDx Recent Developments/Updates
6.11 Biofortuna
6.11.1 Biofortuna Corporation Information
6.11.2 Biofortuna Human Leukocyte Antigen Testing Description and Business Overview
6.11.3 Biofortuna Human Leukocyte Antigen Testing Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Biofortuna Human Leukocyte Antigen Testing Product Portfolio
6.11.5 Biofortuna Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Leukocyte Antigen Testing Industry Chain Analysis
7.2 Human Leukocyte Antigen Testing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Leukocyte Antigen Testing Production Mode & Process
7.4 Human Leukocyte Antigen Testing Sales and Marketing
7.4.1 Human Leukocyte Antigen Testing Sales Channels
7.4.2 Human Leukocyte Antigen Testing Distributors
7.5 Human Leukocyte Antigen Testing Customers
8 Human Leukocyte Antigen Testing Market Dynamics
8.1 Human Leukocyte Antigen Testing Industry Trends
8.2 Human Leukocyte Antigen Testing Market Drivers
8.3 Human Leukocyte Antigen Testing Market Challenges
8.4 Human Leukocyte Antigen Testing Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Human Leukocyte Antigen Testing Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Human Leukocyte Antigen Testing Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Human Leukocyte Antigen Testing Market Competitive Situation by Manufacturers in 2023
Table 4. Global Human Leukocyte Antigen Testing Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Human Leukocyte Antigen Testing Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Human Leukocyte Antigen Testing Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Human Leukocyte Antigen Testing Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Human Leukocyte Antigen Testing Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Human Leukocyte Antigen Testing, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Leukocyte Antigen Testing, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Leukocyte Antigen Testing, Product Type & Application
Table 12. Global Key Manufacturers of Human Leukocyte Antigen Testing, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Leukocyte Antigen Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Leukocyte Antigen Testing as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Leukocyte Antigen Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Human Leukocyte Antigen Testing Sales by Region (2019-2024) & (K Units)
Table 18. Global Human Leukocyte Antigen Testing Sales Market Share by Region (2019-2024)
Table 19. Global Human Leukocyte Antigen Testing Sales by Region (2025-2030) & (K Units)
Table 20. Global Human Leukocyte Antigen Testing Sales Market Share by Region (2025-2030)
Table 21. Global Human Leukocyte Antigen Testing Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Human Leukocyte Antigen Testing Revenue Market Share by Region (2019-2024)
Table 23. Global Human Leukocyte Antigen Testing Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Human Leukocyte Antigen Testing Revenue Market Share by Region (2025-2030)
Table 25. North America Human Leukocyte Antigen Testing Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Human Leukocyte Antigen Testing Sales by Country (2019-2024) & (K Units)
Table 27. North America Human Leukocyte Antigen Testing Sales by Country (2025-2030) & (K Units)
Table 28. North America Human Leukocyte Antigen Testing Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Human Leukocyte Antigen Testing Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Human Leukocyte Antigen Testing Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Human Leukocyte Antigen Testing Sales by Country (2019-2024) & (K Units)
Table 32. Europe Human Leukocyte Antigen Testing Sales by Country (2025-2030) & (K Units)
Table 33. Europe Human Leukocyte Antigen Testing Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Human Leukocyte Antigen Testing Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Human Leukocyte Antigen Testing Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Human Leukocyte Antigen Testing Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Human Leukocyte Antigen Testing Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Human Leukocyte Antigen Testing Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Human Leukocyte Antigen Testing Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Leukocyte Antigen Testing Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Human Leukocyte Antigen Testing Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Human Leukocyte Antigen Testing Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Human Leukocyte Antigen Testing Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Human Leukocyte Antigen Testing Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Human Leukocyte Antigen Testing Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Human Leukocyte Antigen Testing Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Human Leukocyte Antigen Testing Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Human Leukocyte Antigen Testing Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Human Leukocyte Antigen Testing Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Human Leukocyte Antigen Testing Sales (K Units) by Type (2019-2024)
Table 51. Global Human Leukocyte Antigen Testing Sales (K Units) by Type (2025-2030)
Table 52. Global Human Leukocyte Antigen Testing Sales Market Share by Type (2019-2024)
Table 53. Global Human Leukocyte Antigen Testing Sales Market Share by Type (2025-2030)
Table 54. Global Human Leukocyte Antigen Testing Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Human Leukocyte Antigen Testing Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Human Leukocyte Antigen Testing Revenue Market Share by Type (2019-2024)
Table 57. Global Human Leukocyte Antigen Testing Revenue Market Share by Type (2025-2030)
Table 58. Global Human Leukocyte Antigen Testing Price (US$/Unit) by Type (2019-2024)
Table 59. Global Human Leukocyte Antigen Testing Price (US$/Unit) by Type (2025-2030)
Table 60. Global Human Leukocyte Antigen Testing Sales (K Units) by Application (2019-2024)
Table 61. Global Human Leukocyte Antigen Testing Sales (K Units) by Application (2025-2030)
Table 62. Global Human Leukocyte Antigen Testing Sales Market Share by Application (2019-2024)
Table 63. Global Human Leukocyte Antigen Testing Sales Market Share by Application (2025-2030)
Table 64. Global Human Leukocyte Antigen Testing Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Human Leukocyte Antigen Testing Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Human Leukocyte Antigen Testing Revenue Market Share by Application (2019-2024)
Table 67. Global Human Leukocyte Antigen Testing Revenue Market Share by Application (2025-2030)
Table 68. Global Human Leukocyte Antigen Testing Price (US$/Unit) by Application (2019-2024)
Table 69. Global Human Leukocyte Antigen Testing Price (US$/Unit) by Application (2025-2030)
Table 70. Thermo Fisher Scientific Corporation Information
Table 71. Thermo Fisher Scientific Description and Business Overview
Table 72. Thermo Fisher Scientific Human Leukocyte Antigen Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Thermo Fisher Scientific Human Leukocyte Antigen Testing Product
Table 74. Thermo Fisher Scientific Recent Developments/Updates
Table 75. F. Hoffman-La Roche Corporation Information
Table 76. F. Hoffman-La Roche Description and Business Overview
Table 77. F. Hoffman-La Roche Human Leukocyte Antigen Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. F. Hoffman-La Roche Human Leukocyte Antigen Testing Product
Table 79. F. Hoffman-La Roche Recent Developments/Updates
Table 80. Bio-Rad Laboratories Corporation Information
Table 81. Bio-Rad Laboratories Description and Business Overview
Table 82. Bio-Rad Laboratories Human Leukocyte Antigen Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bio-Rad Laboratories Human Leukocyte Antigen Testing Product
Table 84. Bio-Rad Laboratories Recent Developments/Updates
Table 85. QIAGEN N.V. Corporation Information
Table 86. QIAGEN N.V. Description and Business Overview
Table 87. QIAGEN N.V. Human Leukocyte Antigen Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. QIAGEN N.V. Human Leukocyte Antigen Testing Product
Table 89. QIAGEN N.V. Recent Developments/Updates
Table 90. Illumina Corporation Information
Table 91. Illumina Description and Business Overview
Table 92. Illumina Human Leukocyte Antigen Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Illumina Human Leukocyte Antigen Testing Product
Table 94. Illumina Recent Developments/Updates
Table 95. Immucor Corporation Information
Table 96. Immucor Description and Business Overview
Table 97. Immucor Human Leukocyte Antigen Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Immucor Human Leukocyte Antigen Testing Product
Table 99. Immucor Recent Developments/Updates
Table 100. CareDx Corporation Information
Table 101. CareDx Description and Business Overview
Table 102. CareDx Human Leukocyte Antigen Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. CareDx Human Leukocyte Antigen Testing Product
Table 104. CareDx Recent Developments/Updates
Table 105. Becton Dickinson Corporation Information
Table 106. Becton Dickinson Description and Business Overview
Table 107. Becton Dickinson Human Leukocyte Antigen Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Becton Dickinson Human Leukocyte Antigen Testing Product
Table 109. Becton Dickinson Recent Developments/Updates
Table 110. Hologic Corporation Information
Table 111. Hologic Description and Business Overview
Table 112. Hologic Human Leukocyte Antigen Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Hologic Human Leukocyte Antigen Testing Product
Table 114. Hologic Recent Developments/Updates
Table 115. GenDx Corporation Information
Table 116. GenDx Description and Business Overview
Table 117. GenDx Human Leukocyte Antigen Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. GenDx Human Leukocyte Antigen Testing Product
Table 119. GenDx Recent Developments/Updates
Table 120. Biofortuna Corporation Information
Table 121. Biofortuna Description and Business Overview
Table 122. Biofortuna Human Leukocyte Antigen Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Biofortuna Human Leukocyte Antigen Testing Product
Table 124. Biofortuna Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Human Leukocyte Antigen Testing Distributors List
Table 128. Human Leukocyte Antigen Testing Customers List
Table 129. Human Leukocyte Antigen Testing Market Trends
Table 130. Human Leukocyte Antigen Testing Market Drivers
Table 131. Human Leukocyte Antigen Testing Market Challenges
Table 132. Human Leukocyte Antigen Testing Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Leukocyte Antigen Testing
Figure 2. Global Human Leukocyte Antigen Testing Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Human Leukocyte Antigen Testing Market Share by Type in 2023 & 2030
Figure 4. Molecular Assay Technologies Product Picture
Figure 5. Non-molecular Assay Technologies Product Picture
Figure 6. Global Human Leukocyte Antigen Testing Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Human Leukocyte Antigen Testing Market Share by Application in 2023 & 2030
Figure 8. Independent Reference Laboratories
Figure 9. Hospitals & Transplant Centers
Figure 10. Research Laboratories & Academic Institutes
Figure 11. Global Human Leukocyte Antigen Testing Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Human Leukocyte Antigen Testing Market Size (2019-2030) & (US$ Million)
Figure 13. Global Human Leukocyte Antigen Testing Sales (2019-2030) & (K Units)
Figure 14. Global Human Leukocyte Antigen Testing Average Price (US$/Unit) & (2019-2030)
Figure 15. Human Leukocyte Antigen Testing Report Years Considered
Figure 16. Human Leukocyte Antigen Testing Sales Share by Manufacturers in 2023
Figure 17. Global Human Leukocyte Antigen Testing Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Human Leukocyte Antigen Testing Players: Market Share by Revenue in 2023
Figure 19. Human Leukocyte Antigen Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Human Leukocyte Antigen Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Human Leukocyte Antigen Testing Sales Market Share by Country (2019-2030)
Figure 22. North America Human Leukocyte Antigen Testing Revenue Market Share by Country (2019-2030)
Figure 23. United States Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Human Leukocyte Antigen Testing Sales Market Share by Country (2019-2030)
Figure 26. Europe Human Leukocyte Antigen Testing Revenue Market Share by Country (2019-2030)
Figure 27. Germany Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Human Leukocyte Antigen Testing Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Human Leukocyte Antigen Testing Revenue Market Share by Region (2019-2030)
Figure 34. China Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Human Leukocyte Antigen Testing Sales Market Share by Country (2019-2030)
Figure 44. Latin America Human Leukocyte Antigen Testing Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Human Leukocyte Antigen Testing Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Human Leukocyte Antigen Testing Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Human Leukocyte Antigen Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Human Leukocyte Antigen Testing by Type (2019-2030)
Figure 54. Global Revenue Market Share of Human Leukocyte Antigen Testing by Type (2019-2030)
Figure 55. Global Human Leukocyte Antigen Testing Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Human Leukocyte Antigen Testing by Application (2019-2030)
Figure 57. Global Revenue Market Share of Human Leukocyte Antigen Testing by Application (2019-2030)
Figure 58. Global Human Leukocyte Antigen Testing Price (US$/Unit) by Application (2019-2030)
Figure 59. Human Leukocyte Antigen Testing Value Chain
Figure 60. Human Leukocyte Antigen Testing Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
